Tesla Inc.’s stock rose 2% early Tuesday, boosted by expectations that Chief Executive Elon Musk’s close relationship with ...
This might be the perfect time to add exposure to value stocks, with growth stocks having lead to high price ratios for the S ...
Smithfield Foods Inc. is offering Wall Street a seat at the table for potential growth in its packaged meats business as the ...
Stocks are not doomed for the rest of this year just because January’s low was below December’s low.
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
After e-commerce demand led to an expansion in the industrial real-estate market during the pandemic, warehouse construction has slowed. This dynamic has led Prologis, the world's largest industrial ...
J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.
Revance on Tuesday said it signed a revised merger agreement with privately held Crown, which has extended its tender offer for the Nashville, Tenn., biotechnology company to Feb. 4. Crown raised its ...
Dynacor Group reported strong sales in December, bringing the company's full-year performance to the top end of its range. The Canadian gold ore processing company said Tuesday that gold sales reached ...
Canaan shares rose Tuesday after the company reported a 2025 revenue outlook far above previous company results due to rising demand for bitcoin mining power. Shares of the crypto miner were recently ...
FTAI said it strongly disagrees with the report's claims, but will likely need time to review them thoroughly as it prepares audited financial statements for fiscal 2024. As a result, the filing of ...
Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its ...